Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19
2021; American Medical Association; Volume: 181; Issue: 9 Linguagem: Inglês
10.1001/jamainternmed.2021.2209
ISSN2168-6114
AutoresXavier Mariette, Olivier Hermine, Pierre‐Louis Tharaux, Matthieu Resche‐Rigon, Philippe Gabríel Steg, Raphaël Porcher, Philippe Ravaud,
Tópico(s)Vitamin C and Antioxidants Research
ResumoThis follow-up study of the CORIMUNO-TOCI-1 randomized clinical trial examines the association between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.
Referência(s)